DUBLIN--(BUSINESS WIRE)--The "Histology and Cytology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Histology and Cytology estimated at US$12.3 Billion in the year 2020, is projected to reach a revised size of US$28.7 Billion by 2027, growing at a CAGR of 12.9% over the period 2020-2027.
Cytology, one of the segments analyzed in the report, is projected to record 13.5% CAGR and reach US$18.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Histology segment is readjusted to a revised 11.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 12.4% CAGR
The Histology and Cytology market in the U.S. is estimated at US$3.6 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$5 Billion by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 10.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.
Select Competitors (Total 42 Featured):
- Abbott Laboratories
- Becton, Dickinson and Company
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Hologic, Inc.
- Merck KgaA
- PerkinElmer, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Trivitron Healthcare
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/9ul7fl
